# Deep Learning Framework for Early Detection of Pancreatic Cancer Using Multi-Modal Medical Imaging Analysis

**Authors:** Dennis Slobodzian, Amir Kordijazi

arXiv: 2508.20877 · 2025-09-12

## TL;DR

This paper presents a deep learning framework that combines dual-modality medical imaging analysis to enable early detection of pancreatic cancer, achieving over 90% accuracy and addressing challenges like limited data and class imbalance.

## Contribution

It introduces a specialized neural network architecture optimized for small medical datasets, integrating autofluorescence and SHG imaging modalities for improved PDAC detection.

## Key findings

- Achieved over 90% accuracy in cancer detection
- Compared CNNs and Vision Transformers for medical imaging
- Developed a pipeline addressing dataset limitations

## Abstract

Pacreatic ductal adenocarcinoma (PDAC) remains one of the most lethal forms of cancer, with a five-year survival rate below 10% primarily due to late detection. This research develops and validates a deep learning framework for early PDAC detection through analysis of dual-modality imaging: autofluorescence and second harmonic generation (SHG). We analyzed 40 unique patient samples to create a specialized neural network capable of distinguishing between normal, fibrotic, and cancerous tissue. Our methodology evaluated six distinct deep learning architectures, comparing traditional Convolutional Neural Networks (CNNs) with modern Vision Transformers (ViTs). Through systematic experimentation, we identified and overcome significant challenges in medical image analysis, including limited dataset size and class imbalance. The final optimized framework, based on a modified ResNet architecture with frozen pre-trained layers and class-weighted training, achieved over 90% accuracy in cancer detection. This represents a significant improvement over current manual analysis methods an demonstrates potential for clinical deployment. This work establishes a robust pipeline for automated PDAC detection that can augment pathologists' capabilities while providing a foundation for future expansion to other cancer types. The developed methodology also offers valuable insights for applying deep learning to limited-size medical imaging datasets, a common challenge in clinical applications.

---
Source: https://tomesphere.com/paper/2508.20877